|
FY2024
12 months to Nov 30, 2024
|
FY2023
12 months to Nov 30, 2023
|
FY2022
12 months to Nov 30, 2022
|
|
|---|---|---|---|
| Cash flows from operating activities: | |||
| Net income | |||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||
| Interest earned on cash held in Trust Account | |||
| Changes in operating assets and liabilities: | |||
| Prepaid expenses | |||
| Accounts payable | |||
| Accrued expenses | |||
| Advanced by related parties | |||
| Other payables | |||
| Net cash used in operating activities | |||
| Cash flows from investing activities: | |||
| Cash withdrawn from Trust Account in connection with redemption | |||
| Investment of cash in Trust Account | |||
| Net cash provided by investing activities | |||
| Cash flows from financing activities: | |||
| Redemption of ordinary shares | |||
| Proceeds from working capital loan | |||
| Proceeds from extension loan | |||
| Collection of subscription receivable | |||
| Proceeds from sale of Units, net of IPO costs | |||
| Proceeds from sale of private placement units | |||
| Repayment of promissory note – related party | |||
| Net cash used in financing activities | |||
| Net change in cash | |||
| Cash at the beginning of the period | |||
| Cash at the end of the period | |||
| Supplemental disclosure of non-cash investing and financing activities: | |||
| Remeasurement of Common Stock subject to redemption | |||
| Extension Funds attributable to Common Stock subject to redemption | |||
| Deferred underwriting fee payable | |||
| Initial Classification of Class A ordinary shares subject to redemption | |||
| Deferred offering costs paid for by Promissory note – related party |
Loading...
